{"id":7730,"date":"2026-02-24T08:15:00","date_gmt":"2026-02-24T07:15:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/"},"modified":"2026-02-24T08:15:00","modified_gmt":"2026-02-24T07:15:00","slug":"valberedning-infor-arsstamman-2026-i-nanexa-ab-publ","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/","title":{"rendered":"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ)"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) har utsetts.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p>Valberedningens ledam\u00f6ter utg\u00f6rs av:<\/p>\n<ul>\n<li>Marlon V\u00e4rnik, Exelity<\/li>\n<li>Jonas P\u00e5lsson<\/li>\n<li>G\u00f6ran Ando, styrelseordf\u00f6rande, adjungerad<\/li>\n<\/ul>\n<p>Valberedningens f\u00f6rslag kommer att presenteras i kallelsen till \u00e5rsst\u00e4mman 2026 samt p\u00e5 bolagets hemsida <a href=\"http:\/\/www.nanexa.com\/\" rel=\"noopener\" target=\"_blank\">www.nanexa.com<\/a>.<\/p>\n<p>Aktie\u00e4gare kan kontakta valberedningen med f\u00f6rslag avseende dess arbete genom att s\u00e4nda e-mail till <a href=\"mailto:info@nanexa.se\" rel=\"noopener\" target=\"_blank\">info@nanexa.se<\/a> (rubrik \u201dNanexas valberedning\u201d) eller via brev till: Nanexa AB, Att: Nanexas valberedning, Virdings all\u00e9 2, SE-754 50 Uppsala.<\/p>\n<p>\u00c5rsst\u00e4mman kommer att h\u00e5llas i Uppsala den 12 maj 2026.<\/p>\n<p><strong>F\u00f6r mer information kontakta:<\/strong><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-2376405b3437\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information kontakta:<\/strong><\/p>\n<hr \/>\n<p>David Westberg \u2013 vd, Nanexa AB (publ)\u00a0<br \/>Telefon: 0709-42 83 03<br \/>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\" rel=\"noopener\" target=\"_blank\">david.westberg@nanexa.se<\/a><br \/><a href=\"http:\/\/www.nanexa.com\" rel=\"noopener\" target=\"_blank\">www.nanexa.com<\/a><\/p>\n<p>Bolagets Certified Adviser \u00e4r Tapper Partners AB.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-c9ba281e2dde\">\n<p><strong class=\"mfn-heading-1\">Om Nanexa AB (publ)<\/strong><\/p>\n<hr \/>\n<p>Nanexa introducerar kontroll, precision och m\u00e5ngsidighet till l\u00e4kemedelsformuleringar med hj\u00e4lp av ALD-teknik (Atomic Layer Deposition). F\u00f6retagets patenterade PharmaShell\u00ae-plattform \u00e4r ett unikt drug delivery-system som m\u00f6jligg\u00f6r h\u00f6g drug load vilket ger l\u00e5g injektionsvolym och skapar en ny generation formuleringar, s\u00e5 kallade \u201dsuper generics\u201d som ger st\u00f6rre bekv\u00e4mlighet och minskar kostnaderna vid behandling av allehanda sjukdomstillst\u00e5nd som metabola sjukdomar, t ex typ 2-diabetes och obesitas, hematologi\/onkologi, hj\u00e4rt-k\u00e4rlsjukdomar, psykiatri och m\u00e5nga andra.<br \/>Nanexa utvecklar egna l\u00e4kemedelsprodukter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland det senaste licens- och optionsavtalet med Moderna.<\/p>\n<p>Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr \/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/f5343bdd-f88c-4ca5-916b-d277bbae89fd\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ.pdf\" rel=\"noopener\" target=\"_blank\">Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ)<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) har utsetts.<\/p>\n","protected":false},"template":"","class_list":["post-7730","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-ext-nq_sv","mfn-news-tag-mfn-ext-nq-company-announcement_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) har utsetts.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\\\/\",\"name\":\"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2026-02-24T07:15:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/mfn_news\\\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/","og_locale":"sv_SE","og_type":"article","og_title":"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) - Nanexa AB","og_description":"Valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) har utsetts.","og_url":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/","url":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/","name":"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ) - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2026-02-24T07:15:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/sv\/mfn_news\/valberedning-infor-arsstamman-2026-i-nanexa-ab-publ\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Valberedning inf\u00f6r \u00e5rsst\u00e4mman 2026 i Nanexa AB (publ)"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}